FDA approves once-monthly treatment for anemic adults on dialysis Full Text
Drug Topics, 04/05/2012
FDA has approved peginesatide to treat anemia in adult dialysis patients who have chronic kidney disease (CKD). The product will be co–marketed in the United States with Takeda Pharmaceutical Company Ltd., according to The Wall Street Journal.



